Investigating Pfk13 mutations in Plasmodium falciparum natural populations from two malaria-endemic areas of Cameroon
- PMID: 40219818
- DOI: 10.1093/trstmh/traf040
Investigating Pfk13 mutations in Plasmodium falciparum natural populations from two malaria-endemic areas of Cameroon
Abstract
Background: The emergence of Plasmodium falciparum resistance to artemisinin is a huge concern in Africa. We investigated and characterized mutations of Pfk13 propeller sequences from P. falciparum isolates across two endemic areas with different eco-geographical settings in Cameroon.
Methods: A total of 259 dried blood spot samples were collected through a cross-sectional survey in two health facilities located in Bimengue (rural area) and the Efoulan District Hospital in Yaoundé (urban area). The molecular analysis of Pfk13 was performed using nested polymerase chain reaction followed by Sanger sequencing.
Results: Our findings highlight that of the 23 mutations found, most of the genetic variants were observed in Yaoundé, suggesting a possible higher drug pressure in this locality. Three Pfk13 mutations (F446S, C469W and A681D) were found in polymorphic sites known to be associated with artemisinin resistance, but with different amino acid substitutions. In addition, three other mutations have already been reported to circulate in other African countries, with an unknown impact on delayed response to artemisinin therapy (P475L, S477F and F628L).
Conclusions: Although there is an absence of validated artemisinin resistance-associated polymorphisms in the study, the results highlight the need for further studies to quantify the frequency of these and other Pfk13 gene polymorphisms over time.
Keywords: Pfk13 gene; Plasmodium falciparum malaria; Cameroon; artemisinin resistance; urban and rural malaria.
© The Author(s) 2025. Published by Oxford University Press on behalf of Royal Society of Tropical Medicine and Hygiene.
Similar articles
-
Novel Plasmodium falciparum Kelch13 polymorphisms in Cameroon with structural and physicochemical impact.Antimicrob Agents Chemother. 2025 May 7;69(5):e0088424. doi: 10.1128/aac.00884-24. Epub 2025 Apr 14. Antimicrob Agents Chemother. 2025. PMID: 40227034 Free PMC article.
-
Artemisinin and partner drug resistance markers in Plasmodium falciparum from Tanzanian paediatric malaria patients, 2016-2022.Malar J. 2025 Jul 1;24(1):209. doi: 10.1186/s12936-025-05447-x. Malar J. 2025. PMID: 40598187 Free PMC article.
-
Screening for antifolate and artemisinin resistance in Plasmodium falciparum dried-blood spots from three hospitals of Eritrea.F1000Res. 2024 Jun 12;10:628. doi: 10.12688/f1000research.54195.4. eCollection 2021. F1000Res. 2024. PMID: 38840941 Free PMC article.
-
Primaquine or other 8-aminoquinoline for reducing P. falciparum transmission.Cochrane Database Syst Rev. 2014 Jun 30;(6):CD008152. doi: 10.1002/14651858.CD008152.pub3. Cochrane Database Syst Rev. 2014. Update in: Cochrane Database Syst Rev. 2015 Feb 19;(2):CD008152. doi: 10.1002/14651858.CD008152.pub4. PMID: 24979199 Free PMC article. Updated.
-
Mapping Antimalarial Drug Resistance in Mozambique: A Systematic Review of Plasmodium falciparum Genetic Markers Post-ACT Implementation.Int J Mol Sci. 2024 Dec 20;25(24):13645. doi: 10.3390/ijms252413645. Int J Mol Sci. 2024. PMID: 39769406 Free PMC article.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources